Teva Pharmaceutical Industries Ltd ADR diskutieren
Teva Pharmaceutical Industries Ltd ADR
WKN: 883035 / Symbol: TEVA / Name: Teva Pharma / Aktie / Pharmazeutika / Large Cap /
15,80 €
-1,25 %
Teva Pharmaceutical Industries Limited (NYSE: TEVA) had its price target raised by analysts at Barclays PLC from $20.00 to $21.00. They now have an "overweight" rating on the stock.
Ratings data for TEVA provided by MarketBeat
Teva Pharmaceutical Industries Limited (NYSE: TEVA) had its price target raised by analysts at Jefferies Financial Group Inc. from $19.00 to $23.00. They now have a "buy" rating on the stock.
Ratings data for TEVA provided by MarketBeat
Teva Pharmaceutical Industries Limited (NYSE: TEVA) was upgraded by analysts at Argus from a "hold" rating to a "buy" rating. They now have a $20.00 price target on the stock.
Ratings data for TEVA provided by MarketBeat
Teva Pharmaceutical Industries Limited (NYSE: TEVA) had its price target raised by analysts at UBS Group AG from $22.00 to $24.00. They now have a "buy" rating on the stock.
Ratings data for TEVA provided by MarketBeat
Teva Pharmaceutical Industries Limited (NYSE: TEVA) had its price target raised by analysts at Barclays PLC from $21.00 to $22.00. They now have an "overweight" rating on the stock.
Ratings data for TEVA provided by MarketBeat
Teva Pharmaceutical Industries Limited (NYSE: TEVA) was upgraded by analysts at StockNews.com from a "buy" rating to a "strong-buy" rating.
Ratings data for TEVA provided by MarketBeat
Teva Pharmaceutical Industries Limited (NYSE: TEVA) had its price target raised by analysts at UBS Group AG from $24.00 to $26.00. They now have a "buy" rating on the stock.
Ratings data for TEVA provided by MarketBeat
Neueste Beiträge
Doreolland in Duke Energy Corp. diskutieren